SubhashBanerjeeMDFACC, FSCAI

Cardiology • Dallas, TX

Adult Congenital Heart Disease, Interventional Cardiology

Associate Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School

Join to view full profile

Dr. Banerjee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Banerjee's full profile

Already have an account?

Office
4500 S Lancaster Rd
Dallas, TX 75216
Phone+1 214-742-8388

Fax+1 214-302-1341

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Interventional Cardiology, 2002 - 2003
University of Iowa Hospitals and ClinicsFellowship, Cardiovascular Disease, 1999 - 2002
New York-Presbyterian/QueensResidency, Internal Medicine, 1996 - 1999
Minsk Medical InstituteClass of 1992

Certifications & Licensure

TX State Medical License 2005 - 2026
OH State Medical License 2017 - 2019
NM State Medical License 2003 - 2008
IA State Medical License 1999 - 2006
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial) Start of enrollment: 2008 Sep 11
Completed
Not Applicable
Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease Start of enrollment: 2008 Nov 01
Completed
Not Applicable
Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft Lesions Start of enrollment: 2009 May 01
Completed
Phase 4
Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I Start of enrollment: 2011 Sep 01
Completed
Phase 3
AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO Study Start of enrollment: 2009 Nov 01
Completed
Phase 4
Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed Start of enrollment: 2009 Sep 01
Completed
Phase 4
Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis Start of enrollment: 2010 Oct 01
Completed
Phase 2
Effect of a Real Time Radiation Monitoring Device on Radiation Exposure During Cardiac Catheterization Start of enrollment: 2012 Jan 01
Completed
Phase 3
Chocolate Balloon Angioplasty Registry Start of enrollment: 2012 May 01
Completed
Impact of Coronary Anatomy on Angina Relief in Patients Undergoing Coronary Revascularization Start of enrollment: 2003 Jan 01
Completed
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes Start of enrollment: 2013 Jan 01
Recruiting
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN Start of enrollment: 2013 Dec 01
Completed
Not Applicable
Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities Start of enrollment: 2015 Nov 01
Completed
Phase 3
JetStream Atherectomy for the Treatment of In-stent Restenosis Start of enrollment: 2016 Apr 01
Completed
Not Applicable
Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD Start of enrollment: 2017 Apr 10
Unknown status
Phase 4
Non-Complex Biliary Stones DSC vs ERC Start of enrollment: 2018 Sep 21
Completed
Not Applicable
Excellence in Peripheral Arterial Disease Treatment of Superficial Femoral Artery Disease With Drug-eluting Stents Start of enrollment: 2014 Jan 01
Terminated
Not Applicable
The Perioperative Management of Anti-thrombotic Drug Registry Start of enrollment: 2018 Jan 31
Completed
Management of Antiplatelet Regimen During Surgical Procedures Start of enrollment: 2019 Aug 01
Recruiting
Roles: Contact, Study Chair, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

15 citations
Mid-term outcomes of chronic total occlusion percutaneous coronary intervention with subadventitial vs. intraplaque crossing: A systematic review and meta-analysis
Aris Karatasakis, Barbara A. Danek, Judit Karacsonyi, Lorenzo Azzalini, Mauro Carlino
International Journal of Cardiology. 2018-02-15
242 citations
Development and Validation of a Novel Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Interventions: The PROGRESS CTO ...
Georgios Christopoulos, David E. Kandzari, Robert W. Yeh, Farouc A. Jaffer, Dimitri Karmpaliotis
JACC. Cardiovascular Interventions. 2016-01-11
140 citations
The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry.
Peter Tajti, Dimitri Karmpaliotis, Khaldoon Alaswad, Farouc A. Jaffer, Robert W. Yeh
JACC. Cardiovascular Interventions. 2018-07-23

Lectures

Development of Peripheral CTO Algorithms
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
My Toughest SFA Case of the Year
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
Challenges in NSTEMI Management: It's Not Always 'Easy Street'!
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Interventional Live Case Session II: Peripheral Transmission from Piedmont Heart Institute
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
VIVA 12—The National Education Course in Vascular Medicine and Intervention
The American Board of Vascular Medicine, Las Vegas, Nevada - 10/6/2012
Join now to see all

Authored Content

A New Treatment Strategy for Saphenous Vein Graft Lesions? Letting It GoApril 2018

Press Mentions

Perioperative Management of Patients with Coronary StentsJune 29th, 2022
Lithotripsy Advantage in Calcified Peripheral Vessels Holds up at 1 YearMay 19th, 2022
Real-World, Low-Risk Patients Fare Well with Self-Expanding Evolut PROJune 24th, 2020
Join now to see all